L
LB Pharmaceuticals Inc
NASDAQ:LBRX
LB Pharmaceuticals Inc
NASDAQ:LBRX
Price:
24.34
USD
-7.42%
Market Closed
Market Cap:
$615.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
LB Pharmaceuticals Inc
NASDAQ:LBRX
|
US |
|
E
|
Electricite de France SA
LSE:0HBA
|
FR |
|
T
|
TRX Gold Corp
AMEX:TRX
|
CA |
|
G
|
Guangdong Shirongzhaoye Co Ltd
SZSE:002016
|
CN |
|
Mkango Resources Ltd
XTSX:MKA
|
CA |
|
Jiangsu Hagong Intelligent Robot Co Ltd
SZSE:000584
|
CN |
Income Statement
Earnings Waterfall
LB Pharmaceuticals Inc
LB Pharmaceuticals Inc
Income Statement
LB Pharmaceuticals Inc
LB Pharmaceuticals Inc
Currency:
| Sep-2025 | Dec-2025 | ||
|---|---|---|---|
| Revenue | |||
| Revenue |
0
N/A
|
0
N/A
|
|
| Operating Income | |||
| Operating Expenses |
(22)
|
(30)
|
|
| Selling, General & Administrative |
(13)
|
(14)
|
|
| Research & Development |
(9)
|
(17)
|
|
| Operating Income |
(22)
N/A
|
(30)
-38%
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
3
|
5
|
|
| Pre-Tax Income |
(19)
N/A
|
(25)
-34%
|
|
| Net Income | |||
| Tax Provision |
(0)
|
(0)
|
|
| Income from Continuing Operations |
(19)
|
(25)
|
|
| Net Income (Common) |
(19)
N/A
|
(25)
-34%
|
|
| EPS (Diluted) |
-0.74
N/A
|
-1
-35%
|
|
Switch to:
Switch to:
See Also
Discover More
